BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18283314)

  • 1. Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells.
    Akinmade D; Talukder AH; Zhang Y; Luo WM; Kumar R; Hamburger AW
    Br J Cancer; 2008 Mar; 98(6):1132-40. PubMed ID: 18283314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tamoxifen sensitivity by a PAK1-EBP1 signalling pathway in breast cancer.
    Ghosh A; Awasthi S; Peterson JR; Hamburger AW
    Br J Cancer; 2013 Feb; 108(3):557-63. PubMed ID: 23361053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the ErbB3 binding protein Ebp1 by protein kinase C.
    Lessor TJ; Hamburger AW
    Mol Cell Endocrinol; 2001 Apr; 175(1-2):185-91. PubMed ID: 11325528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1.
    Zhang Y; Akinmade D; Hamburger AW
    Cancer Lett; 2008 Jul; 265(2):298-306. PubMed ID: 18355957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance.
    Zhang Y; Linn D; Liu Z; Melamed J; Tavora F; Young CY; Burger AM; Hamburger AW
    Mol Cancer Ther; 2008 Oct; 7(10):3176-86. PubMed ID: 18852121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells.
    Lu Y; Zhou H; Chen W; Zhang Y; Hamburger AW
    Breast Cancer Res Treat; 2011 Feb; 126(1):27-36. PubMed ID: 20379846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of tyrosine 285 of PAK1 facilitates βPIX/GIT1 binding and adhesion turnover.
    Hammer A; Oladimeji P; De Las Casas LE; Diakonova M
    FASEB J; 2015 Mar; 29(3):943-59. PubMed ID: 25466889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcription.
    Zhang Y; Hamburger AW
    J Biol Chem; 2004 Jun; 279(25):26126-33. PubMed ID: 15073182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases.
    Zhang Y; Woodford N; Xia X; Hamburger AW
    Nucleic Acids Res; 2003 Apr; 31(8):2168-77. PubMed ID: 12682367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies.
    Hamburger AW
    J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):225-33. PubMed ID: 18425425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling.
    Zhang Y; Hamburger AW
    Br J Cancer; 2005 Jan; 92(1):140-6. PubMed ID: 15583694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase.
    Adam L; Vadlamudi R; Kondapaka SB; Chernoff J; Mendelsohn J; Kumar R
    J Biol Chem; 1998 Oct; 273(43):28238-46. PubMed ID: 9774445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebp1-mediated inhibition of cell growth requires serine 363 phosphorylation.
    Akinmade D; Lee M; Zhang Y; Hamburger AW
    Int J Oncol; 2007 Oct; 31(4):851-8. PubMed ID: 17786317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
    Holm C; Rayala S; Jirström K; Stål O; Kumar R; Landberg G
    J Natl Cancer Inst; 2006 May; 98(10):671-80. PubMed ID: 16705121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity.
    Rayala SK; Kumar R
    Biomed Pharmacother; 2007 Aug; 61(7):408-11. PubMed ID: 17604944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The investigation of miR-221-3p and PAK1 gene expressions in breast cancer cell lines.
    Ergun S; Tayeb TS; Arslan A; Temiz E; Arman K; Safdar M; Dağlı H; Korkmaz M; Nacarkahya G; Kırkbeş S; Oztuzcu S
    Gene; 2015 Jan; 555(2):377-81. PubMed ID: 25447917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer-RNA-mediated enhancement of ribosomal proteins S6 kinases signaling for cell proliferation.
    Kwon NH; Lee MR; Kong J; Park SK; Hwang BJ; Kim BG; Lee ES; Moon HG; Kim S
    RNA Biol; 2018; 15(4-5):635-648. PubMed ID: 28816616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.
    Awasthi S; Ezelle H; Hassel BA; Hamburger AW
    Mol Cell Biochem; 2015 Jul; 405(1-2):177-86. PubMed ID: 25876877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel Anxa2-interacting protein Ebp1 inhibits cancer proliferation and invasion by suppressing Anxa2 protein level.
    Zhang F; Liu Y; Wang Z; Sun X; Yuan J; Wang T; Tian R; Ji W; Yu M; Zhao Y; Niu R
    Mol Cell Endocrinol; 2015 Aug; 411():75-85. PubMed ID: 25917452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation.
    He HC; Ling XH; Zhu JG; Fu X; Han ZD; Liang YX; Deng YH; Lin ZY; Chen G; Chen YF; Mo RJ; Zhong WD
    Mol Biol Rep; 2013 May; 40(5):3799-805. PubMed ID: 23283744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.